Profile data is unavailable for this security.
About the company
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
- Revenue in USD (TTM)0.00
- Net income in USD-9.89m
- Incorporated2007
- Employees21.00
- LocationENDRA Life Sciences Inc3600 Green Ct Ste 350ANN ARBOR 48105-2440United StatesUSA
- Phone+1 (734) 335-0468
- Fax+1 (302) 655-5049
- Websitehttps://www.endrainc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Advance Inc | -100.00bn | -100.00bn | 985.52k | 3.00 | -- | 0.2506 | -- | -- | -- | -- | -- | 0.0212 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0356 | -- | 100.00 | -- | -21.75 | -- | -- | -- |
| Cannabis Suisse Corp | 30.00k | -254.75k | 987.43k | -- | -- | -- | -- | 32.91 | -0.0057 | -0.0057 | 0.0007 | -0.0103 | 0.0675 | -- | -- | -- | -57.35 | -149.71 | -238.71 | -- | 8.37 | -39.11 | -849.17 | -427.20 | -- | -13.57 | 3.38 | -- | 28.70 | 9.00 | -87.10 | -- | -- | -- |
| GRI Bio Inc | 0.00 | -12.77m | 1.05m | 4.00 | -- | 0.318 | -- | -- | -26.90 | -26.90 | 0.00 | 0.8753 | 0.00 | -- | -- | 0.00 | -382.23 | -192.93 | -869.57 | -353.99 | -- | -- | -- | -37,650.49 | -- | -16.80 | 0.00 | -- | -- | -- | -85.61 | -- | 29.46 | -- |
| VG Life Sciences Inc | 0.00 | -4.30m | 1.05m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
| Yield10 Bioscience Inc | 300.00k | -13.15m | 1.08m | 29.00 | -- | -- | -- | 3.61 | -146.30 | -146.30 | 1.06 | -123.90 | 0.0627 | -- | -- | 10,344.83 | -274.51 | -91.26 | -2,396.54 | -108.09 | -- | -- | -4,381.67 | -2,279.74 | -- | -- | -- | -- | -86.67 | -35.94 | -6.55 | -- | 1.84 | -- |
| Herborium Group, Inc. | 340.33k | -318.65k | 1.09m | 2.00 | -- | -- | -- | 3.21 | -0.3492 | -0.3492 | 0.3672 | -1.16 | 2.32 | 3.89 | 25.94 | -- | -216.97 | -490.56 | -- | -- | 58.31 | 56.36 | -93.63 | -186.81 | 0.0331 | -39.14 | -- | -- | 19.45 | -18.15 | 120.44 | -- | -- | -- |
| ENDRA Life Sciences Inc | 0.00 | -9.89m | 1.11m | 21.00 | -- | 0.2981 | -- | -- | -1.26 | -1.26 | 0.00 | 0.3388 | 0.00 | -- | -- | 0.00 | -168.89 | -132.00 | -228.29 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
| Rimrock Gold Corp | 0.00 | -764.61k | 1.15m | 1.00 | -- | -- | -- | -- | -0.0104 | -0.0104 | 0.00 | -0.00008 | 0.00 | -- | -- | -- | -187.26 | -236.34 | -1,424.92 | -366.85 | -- | -- | -- | -83,418.52 | -- | -1.48 | 1.12 | -- | -- | -- | 30.55 | -- | -- | -- |
| CNS Pharmaceuticals Inc | 0.00 | -17.46m | 1.20m | 3.00 | -- | -- | -- | -- | -179.17 | -179.17 | 0.00 | -20.76 | 0.00 | -- | -- | 0.00 | -384.86 | -132.47 | -- | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
| Vestiage Inc | 0.00 | -21.76k | 1.22m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0011 | 0.00 | -- | -- | -- | -4,945.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
| Bluejay Diagnostics Inc | 0.00 | -9.74m | 1.26m | 10.00 | -- | 0.3457 | -- | -- | -7.68 | -7.68 | 0.00 | 1.25 | 0.00 | -- | -- | 0.00 | -122.06 | -- | -149.68 | -- | -- | -- | -- | -- | -- | -- | 0.0048 | -- | -100.00 | -- | -7.07 | -- | -- | -- |
| Qualigen Therapeutics Inc | 0.00 | -12.48m | 1.26m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
| Bespoke Extracts Inc | 785.45k | -1.48m | 1.30m | 10.00 | -- | -- | -- | 1.66 | -0.1458 | -0.1458 | 0.0774 | -0.1696 | 2.06 | 55.99 | 34.73 | 78,545.00 | -388.21 | -- | -- | -- | 43.69 | -- | -188.79 | -- | 0.0612 | -135.42 | -- | -- | 22,933.72 | -- | 63.98 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Geode Capital Management LLCas of 31 Mar 2024 | 54.24k | 0.49% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 47.91k | 0.43% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 39.81k | 0.36% |
| Jane Street Capital LLCas of 31 Mar 2024 | 36.12k | 0.33% |
| Virtu Americas LLCas of 31 Mar 2024 | 34.64k | 0.31% |
| NewEdge Advisors LLCas of 31 Mar 2024 | 30.94k | 0.28% |
| XTX Markets LLCas of 31 Mar 2024 | 10.76k | 0.10% |
| Tower Research Capital LLCas of 31 Mar 2024 | 8.66k | 0.08% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 332.00 | 0.00% |
| The Northwestern Mutual Life Insurance Co. (Invt Port)as of 31 Mar 2024 | 329.00 | 0.00% |
